CALABRETTA, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.883
AS - Asia 12.408
EU - Europa 10.340
SA - Sud America 2.051
AF - Africa 235
Continente sconosciuto - Info sul continente non disponibili 112
OC - Oceania 21
Totale 56.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.307
GB - Regno Unito 4.123
CN - Cina 3.677
SG - Singapore 3.182
HK - Hong Kong 1.743
BR - Brasile 1.603
IT - Italia 1.392
VN - Vietnam 1.370
SE - Svezia 1.063
DE - Germania 843
UA - Ucraina 702
FI - Finlandia 685
BD - Bangladesh 647
TR - Turchia 455
RU - Federazione Russa 452
FR - Francia 378
KR - Corea 354
CA - Canada 284
BG - Bulgaria 267
IN - India 214
AR - Argentina 164
ID - Indonesia 156
MX - Messico 108
JP - Giappone 103
IQ - Iraq 76
EC - Ecuador 75
NL - Olanda 63
ZA - Sudafrica 59
CO - Colombia 57
PL - Polonia 55
PK - Pakistan 49
VE - Venezuela 48
MA - Marocco 45
AT - Austria 44
AE - Emirati Arabi Uniti 41
IE - Irlanda 41
MY - Malesia 40
BE - Belgio 37
PH - Filippine 35
CR - Costa Rica 34
UZ - Uzbekistan 34
ES - Italia 33
SA - Arabia Saudita 32
EG - Egitto 28
JM - Giamaica 27
CL - Cile 26
EU - Europa 25
DZ - Algeria 23
LT - Lituania 23
PE - Perù 22
TN - Tunisia 22
UY - Uruguay 22
AZ - Azerbaigian 21
NP - Nepal 20
PY - Paraguay 20
CZ - Repubblica Ceca 19
JO - Giordania 19
PT - Portogallo 19
GT - Guatemala 17
IR - Iran 17
AU - Australia 16
KE - Kenya 16
HN - Honduras 15
TH - Thailandia 15
TT - Trinidad e Tobago 14
KZ - Kazakistan 13
OM - Oman 12
SV - El Salvador 12
CH - Svizzera 11
DO - Repubblica Dominicana 11
PR - Porto Rico 11
QA - Qatar 11
BO - Bolivia 10
PS - Palestinian Territory 10
RO - Romania 10
BB - Barbados 9
LB - Libano 9
LV - Lettonia 9
BY - Bielorussia 8
KG - Kirghizistan 8
NI - Nicaragua 8
PA - Panama 7
TW - Taiwan 7
AL - Albania 6
EE - Estonia 6
ET - Etiopia 6
HU - Ungheria 6
MD - Moldavia 6
RS - Serbia 6
SI - Slovenia 6
AO - Angola 5
GE - Georgia 5
GR - Grecia 5
HR - Croazia 5
IL - Israele 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BS - Bahamas 4
Totale 55.880
Salva come PNG Salva come JPEG
Città #
Ashburn 3.189
Southend 3.067
Fairfield 2.813
Woodbridge 2.278
Santa Clara 2.118
Singapore 1.959
Hong Kong 1.731
Houston 1.638
Jacksonville 1.549
San Jose 1.321
Hefei 1.303
Ann Arbor 1.133
Chandler 1.096
Seattle 1.028
Cambridge 1.025
Wilmington 1.016
Dearborn 904
Nyköping 746
Council Bluffs 707
London 625
Beijing 600
Ho Chi Minh City 479
The Dalles 431
Modena 426
Helsinki 423
Los Angeles 422
San Diego 339
Seoul 328
Hanoi 327
New York 326
Princeton 271
Sofia 262
Chicago 258
Eugene 250
Columbus 220
Buffalo 213
Milan 211
Izmir 210
Lauterbourg 208
São Paulo 142
Shanghai 137
Dallas 127
Des Moines 125
Moscow 113
Redwood City 102
Jakarta 93
Phoenix 83
Salt Lake City 83
Falls Church 82
Munich 81
Da Nang 78
Toronto 77
Rome 73
Tokyo 71
Falkenstein 69
Boardman 65
Frankfurt am Main 58
Haiphong 58
Philadelphia 54
North Bergen 52
Norwalk 52
Guangzhou 50
Orem 50
Atlanta 47
Brooklyn 45
Nanjing 42
Warsaw 42
Denver 41
Dublin 40
Mexico City 40
Miano 39
Rio de Janeiro 38
Brasília 37
Tampa 37
San Francisco 36
Belo Horizonte 35
Brussels 35
Kent 35
Nuremberg 34
Chennai 33
Elk Grove Village 33
Montreal 32
Baghdad 31
Johannesburg 30
Quito 30
Curitiba 29
Naples 29
Tashkent 29
Bremen 27
Charlotte 26
Hounslow 26
Verona 26
Biên Hòa 25
Boston 25
San José 25
Dongguan 24
Guayaquil 24
Kilburn 24
Kunming 24
Miami 24
Totale 40.624
Salva come PNG Salva come JPEG
Nome #
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients 461
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 426
Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants 397
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 397
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 396
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 383
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 376
BCR/ABL activates mdm2 rnRNA translation via the La antigen 375
Effects of C/EBP alpha and C/EBP beta in BCR/ABL-expressing cells - Differences and similarities 370
Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis 349
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells 348
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BICRABL-expressing cells 346
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells 340
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. 337
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis 337
Altered expression of G1 specific genes in human malignant myeloid cells. 333
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells viatranscriptional repression of STAT 5 and Mcl-1 329
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 326
Suppression of autophagy by BCR/ABL 325
The p53 Codon 72 Pro/Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients: Correlation with Reduced Apoptosis and Enhanced Senescence by the p53-72P Isoform. 325
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 325
A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells 320
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of bcl-2 expression and Myb-dependent regulation of bcl-2 promoter activity 311
Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 310
Activation of human B-MYB by cyclins. 307
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk 304
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. 303
CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia 301
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients 300
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells 299
BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase. 299
BCR-ABL prevents c-Jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase C beta II-dependent pathway 299
Physical interaction between CDK9 and B-MYB results in suppression of B-MYB gene autoregulation. 297
Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin 297
The transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation 296
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. 296
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. 290
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. 289
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. 288
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis 287
Cell-cycle-dependent expression of human ornithine decarboxylase. 285
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors 280
Positive autoregulation of c-myb expression via myb binding sites in the 5' flanking region of the human c-myb gene 279
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells 279
Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells 278
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide 278
The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. 278
Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo 277
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects 276
Coding sequence and growth regulation of the human vimentin gene. 276
Regulation of Balb/c3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. 271
Ricerca di markers diagnostici, prognostici e predittivi in carcinomi mammari attraverso analisi proteomica 271
Altered mRNA translation: possible mechanism for CML disease progression. 270
Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. 270
Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? 270
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα 268
Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects 267
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. 266
Molecular cloning of a cDNA for a human ADP/ATP carrier which is growth-regulated. 265
The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. 263
Regulation of microRNA-145 by growth arrest and differentiation. 262
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes. 260
B-myb alters the response to myeloid precurson cells to G-CSF 259
Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. 258
Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. 258
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 258
Antisense oligonucleotides. 254
Targeting CDK6 and BCL2 exploits the "MYB addiction" of Phþ acute lymphoblastic leukemia 254
The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain. 252
BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2 251
Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate. 250
Guidelines for the use and interpretation of assays for monitoring autophagy. 250
B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells 249
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction 248
B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. 248
Role of p53 in hematopoietic recovery after cytotoxic treatment. 248
Tumorigenic conversion of p53 deficient colon epithelial cells by an activated Ki-ras gene 248
The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells 247
Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. 247
Characteristics of macromolecular RNA metabolism in leukemic promyelocytes of the HL 60 line 246
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 245
Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells 244
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 244
Granulocytic differentiation of normal hematopoietic precursor cells induced by transcriptional factor PU.1 correlates with negative regulation of the c-myb promoter. 243
Structural and functional analysis of a growth-regulated gene, the human calcyclin 243
Leukemia stem cells: Old concepts and new perspectives 243
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. 242
Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. 242
Direct transactivation of the anti-apoptotic gene Apolipoprotein J (Clusterin) by B-MYB. 241
Translational regulation by the p210 BCR/ABL oncoprotein 240
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model 240
Expression of the Transcriptional Repressor Gfi-1 Is Regulated by C/EBP{alpha} and Is Involved in Its Proliferation and Colony Formation-Inhibitory Effects in p210BCR/ABL-Expressing Cells. 240
Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition 240
Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia 239
TGF-β-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. 238
A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice. 238
Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. 237
Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis 235
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. 235
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant 234
Totale 28.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 218.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 218.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.982 0 0 0 248 127 197 274 218 439 272 738 469
2022/20233.287 442 373 245 304 355 528 79 318 416 36 112 79
2023/20241.946 82 126 134 158 502 183 274 187 43 19 53 185
2024/20257.583 210 29 56 482 1.454 1.048 754 441 808 280 838 1.183
2025/202615.965 965 885 1.720 2.086 1.512 1.093 1.876 949 1.336 1.329 1.201 1.013
2026/20274.281 628 1.035 1.887 731 0 0 0 0 0 0 0 0
Totale 56.050